HIMS NYSE
Hims & Hers Health, Inc.
1W: -1.4%
1M: +1.1%
3M: -24.2%
YTD: -13.2%
1Y: -48.5%
3Y: +366.2%
5Y: +258.0%
$29.00
-0.30 (-1.02%)
Weekly Expected Move ±6.4%
$25
$27
$29
$31
$33
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
-0.90
Bearish
0 bullish
0 neutral
1 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (100)
Hims & Hers Health, Inc. (HIMS) Stock Slides as Market Rises: Facts to Know Before You Trade
Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
Why Hims & Hers Health, Inc. (HIMS) Dipped More Than Broader Market Today
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know
Hims & Hers Chief Legal Officer Soleil Boughton Sells 6,236 Shares
Kaplan Fox Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of a Securities Class Action Deadline on November 2, 2026
10 mid-cap U.S. healthcare stocks with the weakest momentum grades
Baird Financial Group Inc. Raises Holdings in Hims & Hers Health, Inc. $HIMS
Is Hims & Hers Stock a Buy Right Now in September?
Hims & Hers Health, Inc. (HIMS) Falls More Steeply Than Broader Market: What Investors Need to Know
INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - HIMS
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS
I'm Calling It: Hims & Hers Health Will Soar 56% by the End of 2026
Catalyst Watch: FOMC blockbuster, Salesforce event, and 24-hour trading talk
Hims & Hers Health resumed at JP Morgan at neutral on GLP-1 compounding headwinds
Why Is Hims & Hers Health (HIMS) Down 7.7% Since Last Earnings Report?
Hims & Hers Health, Inc. (HIMS) Gains As Market Dips: What You Should Know
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Here's Why Teladoc's Integrated Care Business Deserves More Attention
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law
HIMS Raises 2026 Revenue Outlook as Q2 Sales Rise 38.2% Despite Loss
Reasons to Retain Hims & Hers Stock in Your Portfolio for Now
HIMS INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Hims & Hers Health, Inc. Investors – Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm
Most shorted stocks on Wall Street
Most and least shorted mid- to mega-cap healthcare stocks at the end of August
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Hims & Hers Health, Inc. - HIMS
Thai prostitution warning as 5,000 US sailors arrive in town after 200 days at sea
Trending stocks this week as big tech reports quarterly numbers
After Doubling in Six Months, Is it Too Late to Buy Hims & Hers Stock?
1,333,146 Shares in Hims & Hers Health, Inc. $HIMS Bought by Bank of New York Mellon Corp
Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Hims & Hers Health dips 8% on reports of credit card disputes
National Advertising Division Finds Hims & Hers Has Support for Combination Efficacy Message; Recommends Modification or Discontinuance of Other Claims
BetterHelp Has the Demand: Can Teladoc Build the Capacity?
Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
Hims & Hers Health facing penalties from Visa for credit card disputes - report
Bragar Eagel & Squire, P.C. is Investigating Hims & Hers Health, Inc. on Behalf of Hims & Hers Stockholders and Encourages Investors to Contact the Firm
HIMS Stock More Than Doubled in 6 Months: What's Driving the Rally?
Hims & Hers' Chief Accounting Officer Is Leaving. Here's What Her Latest Insider Filing Shows
An Insider at Hims & Hers Just Filed. Here's What It Says About Buying the Dip
What Long-Term Investors Should Know About This Hims Insider Filing
A Hims & Hers Insider Disposed of Stock as the Company Pushes Into Testosterone and Peptides. Here's What to Know
Hims & Hers' Policy Chief Just Filed an Insider Transaction. Here's What It Means.
An Insider at Hims & Hers Disposed of Over $3 Million in Stock. Here's What Long-Term Investors Should Know
The CTO of Hims & Hers Just Gave Up Nearly $2.7 Million in Stock. Here's What It Actually Means
Hims & Hers' CEO Just Disposed of 78,859 Shares. Here's What Long-Term Investors Should Know.
Hims (HIMS) Q2 2026 Earnings Call Transcript
Notable healthcare headlines for the week: Eli Lilly, Hims & Hers Health, and Merck in focus
Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Hims & Hers’ Revenue Beat Came With a Profitability Problem
Hims & Hers Stock Plunges Post Q2 Earnings Miss, Gross Margin Down
HIMS Q2 Earnings Call Focuses on AI and Global Expansion
Hims & Hers Health, Inc. Q2 2026 Earnings Call Summary
Hims & Hers Health, Inc. (HIMS) Reports Q2 Loss, Tops Revenue Estimates
Key Earnings Reports Ahead
Trading Week Awaits Inflation Reports Starting Wednesday
Earnings Week Ahead: SMCI, CSCO, JD, PLUG, and more
Can Weight-Loss Momentum Lift Hims & Hers Stock Before Q2 Earnings?
Claritev Corporation (CTEV) Reports Q2 Loss, Tops Revenue Estimates
CareCloud, Inc. (CCLD) Lags Q2 Earnings and Revenue Estimates
Hims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for Investors
The FTC Is Suing Hims & Hers Health—Here's Why Investors Shouldn't Panic
Is Hims & Hers Health Stock in Trouble?
Bearish Pressure Is Building Around These 3 Stocks
Hims & Hers Health (HIMS) Faces FTC Lawsuit Over Health Data And Billing - simplywall.st
FTC sues Hims & Hers, saying telehealth company breached patient privacy - The Washington Post
Hims & Hers Promised Users Privacy. The FTC Alleges It Shared Health Data With Meta and Snap - inc.com
Hims & Hers Health, Inc. Stock 12‑Month Price Target Cut to $30.15, Implies 3% Upside - TradingView
US FTC, Utah Sue Hims & Hers Health in Federal Court - Bloomberg.com
FTC sues Hims & Hers, alleging it shared health data with Meta, Snap
Sector Update: Healthcare Stocks Softer Late Afternoon
Hims & Hers Stock Plunges After FTC Sues Over Alleged Privacy Violations - barrons.com
Hims & Hers Stock Plunges After FTC Sues Over Alleged Privacy Violations
Hims & Hers stock sinks after FTC sues over health data sharing and billing - qz.com
FTC sues Hims & Hers over health data sharing, billing
Update: FTC Suing Hims & Hers for Allegedly Sharing User Data With Meta, Snap
Why Is HIMS Stock Down 13% Today?
Why Is HIMS Stock Down 13% Today? - TradingView
Hims and Hers shares fall 10% as FTC sues company over data, billing practices - CNBC
Hims & Hers Responds to FTC Lawsuit - HIMS investor relations
Hims & Hers Responds to FTC Lawsuit
Sector Update: Healthcare Stocks Edge Lower in Afternoon Trading
Hims & Hers stock tumbles on FTC lawsuit over data sharing - Investing.com
US FTC sues Hims & Hers for sending user health info to Meta, Snap
HIMS Stock Eyes Breakout Week: Eight New Partners Fuel Push To Build An All-In-One Health Platform - Stocktwits
HIMS Stock Eyes Comeback After 3-Week Slide: BlackRock Raises Stake, Bulls Bet On Peptide-Fueled Q2 Run
HIMS Stock Heads For Weekly Loss — But Ex-Netflix CFO Is Buying The Dip Despite BofA’s GLP-1 Warning - Stocktwits
Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to Note
Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to Note
Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance Singapore
HIMS Stock Rises Overnight: Retail Traders Bet On Peptides Upside After FDA Panel Backs 6 Of 7 Compounds
HIMS Stock Jumps 14% – Barclays Says Market Is Underestimating Opportunity From New Products - Stocktwits
HIMS Stock Crashes Overnight After Brutal Q1 — But An Investor Says Novo, Lilly Deals Could Make It ‘Netflix Of Healthcare’ - Stocktwits
HIMS Stock Closes Another Day In The Green — But Retail Sees More Upside - Stocktwits
Hims & Hers Health Stock (HIMS) Opinions on FDA Peptide Decisions - Quiver Quantitative
$HIMS stock fell 15% this week. Here's what we see in our data. - Quiver Quantitative
A Hims cofounder fired his entire marketing team for AI. Now his 24/7 online vet service is growing 20% a month